METHOD OF CONTROLLING PLANT PATHOGENS

Abstract: Plants can be transformed to express glucose oxidase from Aspergillus sp. and be made resistant to bacterial and fungal pathogens. Optionally, the plants may also express invertase to increase the available glucose as a substrate for enzymatic activity.

Description: METHOD OF CONTROLLING PLANT PATHOGENS FIELD OF THE INVENTION This invention relates to a method of controlling plant pathogens by a protein which is provided by genetically modifying the plant to produce the protein, and to genes and plants useful in that method. BACKGROUND OF THE INVENTION It is well known that the enzymatic action of glucose oxidase is anti- bacterial. In the presence of oxygen, glucose oxidase catalyzes the oxida¬ tion of glucose to 3-gluconolactone and hydrogen peroxide. The antibac¬ terial mode of action is due to both the oxidative potential of hydrogen peroxide as well as the presence of the 3-gluconolactone, which is a known glycosyltransferase inhibitor. The antibacterial effect of the products of this enzyme has resulted in its widespread use in the food industry, where it is considered a GRAS [generally recognized as safe] compound. As such, glucose oxidase is used to prevent bacterial spoilage of prepared foods. In medicine, it is used as an enzymatic bactericide as part of a preparation for use in wound dressings, toothpicks, dental floss and miniature toothbrushes. Glucose oxidase has also been mentioned as a method to control dental caries- Recent reports have shown that a glucose oxidase is involved as part of the biocontrol mechanism used by Penicillium dangearii to control the plant pathogenic fungus Verticillium dahliae. [Kim et al., 1988, 1990]. However, the use of glucose oxidase as a means for plants to pro¬ tect themselves from pathogenic organisms has been thought to have little potential due to the nature of the enzymatic action. First, there is little free glucose present in plants. The enzyme would seem to have insufficient substrate to produce enough hydrogen peroxide and/or 9-gluconolactone to overcome a pathogenic attack. Second, the presence of such an enzyme in a plant cell, consuming glucose and producing even a small amount of hy¬ drogen peroxide, would be expected to be detrimental to the vitality of the cell. Transgenic plants expressing glucose oxidase would not be expected to develop normally, either as regenerated plants or in subsequent genera- tions. It is an object of the present invention to provide a glucose oxidase than can be safely expressed in plant cells and provide disease resistance to those cells. It is a further object of the present invention to provide a method of transforming plants to express a glucose oxidase which can be safely expressed in plants and provide disease resistance to those plants. SUMMARY OF THE INVENTION Surprisingly, it has been found that the gene for glucose oxidase from Aspergillus niger can be used to transform plants, which are develop- mentally normal and resist pathogenic attack. It is, therefore, an object of the present invention to provide genetic constructs comprising a gene for Aspergillus glucose oxidase (AGO) useful for insertion into plant cells. It is another object of the present invention to provide transformed, pathogen- resistant plants containing such genetic material. Additionally, the plants may also be transformed to co-express other antifungal proteins or insecticidal proteins, for example, using Bacillus thuringiensis (B.t.) genes. Examples of plants transformed to express B.t. genes are disclosed in European Patent Publication No. 0 385 962, which corresponds to U.S. Serial Number 07/476,661, filed February 12, 1990 [Fischhoff et al.], which is incorporated herein by reference. A B.t. gene may be incorporated into a plant of the present invention by simul- taneous transformation, sequential transformation, or by breeding. In accordance with an aspect of the present invention, there is provided a recombinant, double-stranded DNA molecule comprising in operative sequence: a) a promoter which functions in plant cells to cause the production of an RNA sequence; and b) a structural coding sequence that codes for production of AGO; c) a 3' non-translated region which functions in plant cells to cause the addition of polyadenylate nucleotides to the 3' end of the RNA sequence. In accordance with another aspect of the present invention, there is provided a method of producing genetically transformed plants which express an antipathogenic amount of AGO, comprising the steps of: a) inserting into the genome of a plant cell a recombinant, double-stranded DNA molecule comprising (i) a promoter which functions in plant cells to cause the production of an RNA sequence; (ii) a structural coding sequence that codes for production ofAGO; (iii) a 3' non-translated region which functions in said plant cells to cause the addition of polyadenylate nucleotides to the 3' end of the RNA sequence; b) obtaining transformed plant cells; and c) regenerating from the transformed plant cells genetically transformed plants which express an inhibitory amount of AGO. There is also provided, in accordance with another aspect of the present invention, transformed plants that contain DNA comprised of the above-mentioned elements (i), (ii), and (iii). As used herein, the term "Aspergillus glucose oxidase" or "AGO" is used to indicate a glucose oxidase naturally produced by Aspergillus sp. or having >80 homology, preferably >90%, to such an enzyme, for example, the enzyme encoded by SEQ ID NO: 1. As used herein, the term "controlling microbial damage" or "pathogen- resistance" is used to indicate causing a reduction in damage to a crop due to infection by a bacterial or fungal pathogen. As used herein, the term "structural coding sequence" means a DNA sequence which encodes for a polypeptide, which may be made by a cell following transcription of the DNA to mRNA, followed by translation to the desired polypeptide. As used herein, the term "plant locus" means the area immediately surrounding a plant and including the plant and its root zone. DETAILED DESCRIPTION OF THE INVENTION One embodiment of the present invention comprises a protein isola¬ ted from Aspergillus niger. This protein, designated AGO, has been purified to homogeneity. It inhibits the growth of the agronomically important fungal pathogens, including, Verticillium dahliae, one of the most wide¬ spread and damaging plant pathogens, causing disease in many plants, Phytophthora infestans (Pi), the causal pathogen of late blight d sease in potato and tomato, Botrytis cinerea (Be), the source of gray mold on various fruits and vegetables, Septoήa nodorum (Sn), the causal agent of wheat glume blotch, Pseudocercosporella herpotrichoides (Ph), the causal agent of wheat eyespot, and Gaeumannomyces graminis var tritici (Ggt), the causal agent of Take-all disease in cereals, with an amount as httle as 50 ng under the assay conditions. It has also been found to inhibit Erwinia carotovora, the causal agent of potato soft rot, a post-harvest disease of potatoes. It is expected to be capable of controlling many other plant path¬ ogenic organisms based on the products of its enzymatic activity, θ-glu- conolactone and hydrogen peroxide. Each of these byproducts is toxic to such organisms. Many species of plants may be protected by the methods of the present invention. For example, many fruits and vegetables such as straw¬ berries, potatoes, and tomatoes may be protected from plant pathogens by the present methods. Various Phytophthora species are pathogenic to many other plants, such as fruit trees or turf, and thus these plants may also be protected by the methods of the present invention. Furthermore, wheat and barley plants may be protected from Ggt, Sn, and Ph, by the present method. As noted above, the antimicrobial proteins of the present invention may be used in combination with other antifungal proteins so as to provide a broad spectrum of activity, i.e., control additional pathogens, and/or pro¬ vide multiple modes of action for the inhibition of the same fungal patho¬ gen. Sources of such other antifungal proteins might be microbial, such as the proteins of the present invention, or may be plants. Many such anti¬ fungal genes are reported in the literature. Although AGO will function to protect plants from pathogenic attack in the presence of naturally occurring levels of glucose, it may be desirable to provide an invertase which will cause the hydrolysis of sucrose, thus releasing additional glucose for the AGO to act on. The invertase will preferably be a cell wall invertase such as from yeast (EP 0 442 592, Willmitzer et al., 1991, also AU 70898/91) or a vacuolar enzyme such as from tomato or other plants. In these two cases the native signal sequences may be used; however, it may be preferable that the invertase be sequestered until needed in the extracellular space, or not produced until needed. The first alternative may be accomplished by the use of a signal sequence which will direct the enzyme to the extracellular space. One such signal is the potato protease inhibitor signal (Keil et al., 1986; Nelson et al., 1980). A promoter that is only active as a result of a pathogenic infection would be useful in limiting the expression of invertase to when it is actually needed to produce glucose as a substrate for AGO. During storage, when Erwinia infection can cause the loss of a whole bin, potato tubers will naturally contain glucose from the breakdown of starch. Therefore, inclusion of a gene for invertase is not desired or necessary for protection from soft rot. IN VITRO BIOEFFICACY ASSAYS Antifungal assays Glucose oxidase from Aspergillus niger can be obtained from Sigma Chemical Co. (St. Louis, Cat.# G-7141). It was used to test the in vitro activity against several organisms. Tests against Pi and Be were conducted in Medium #303, prepared as follows: One liter contains 1 g MgS0 4 -7H 2 0; 2 g KH 2 P0 4 ; 0.5 g NaCl; 1 g CaC0 3 ; 1 ml ZnS0 4 -7H 2 0 stock- 1 mg/ml; 1 ml FeS0 4 -7H 2 0 stock - 1 mg/ml; 0.5 ml FeEDTA stock - 100 mM; 20 g Maltrin M-100; 20 g Casein; 5 g Yeast Extract; 5 g Glucose; 3.02 g Pipes 10 mM; pH adjusted to 6.5 and filter sterilized. Tests against Ggt were conducted in half-strength PDA (Difco). Tests against Ph were conducted in CDAA .1% media prepared as follows: 35 g/1 Difco Czapek Dox Broth, 1 g/1 Proline, 500 mg 1 Asparagine, 500 mg 1 Cysteine, and 1 g/1 Agar are autoclaved for 23 minutes, and filter- sterilized vitamins (1 ppm Thiamine and 1 ppm Biotin) are added. Be and Pi were tested in a liquid assay in 96-well plates. Be was used at 5 x 102 spores per well and allowed to incubate at 20 °C. for 24-48 hours. Pi is seeded at 5 x 103 sporangia per well and allowed to incubate at 18 °C for 24-48 hours. Assessment of growth is made by measuring the OD at 595 nm. The growth of Pi was 90% inhibited at concentrations as low as 3x10-5 πj/μl. The growth of Be was 95% inhibited at 0.001 IU/μl. Activity against Gaeumannomyces was evaluated on solid agar plates. An approximately 0.5 cm2 piece of agar supporting heavy fungal growth was placed in the center of a half-strength PDA plate and allowed to grow out for several days at 22 °C. At 1 cm beyond the leading edge of growth a 0.5 cm diameter plug of agar was removed aseptically with a sterile cork borer. Sterile AGO stock was added directly to these wells. A visible zone of inhibition was apparent with amounts as low as 0.02 IU/well. Tests against Ph were conducted in 96-well plates. A 14 day old cul¬ ture of Pseudocercosporella herpotrichoides var. tritici on water agar is used to make the spore suspension. A plate is flooded with 5-10 ml of CDAA .1% media and spores are mixed into the liquid media by swirling gently. The concentrated spore suspension is drawn off * with pipet and added to the total volume of CDAA required for the test, adjusting spore concentration to 100,000 spores/ml. Assay incubation is at 24° C in darkness. The spore suspension is dispensed at 50 μl well in a 96 well micro- titer plate. These plates are then placed in an incubator (10 hr/day light at 12 °C) for 24 hours prior to sample application. 50 μl of sample is added to the 50 μl of inoculum (prepared 24 hours earlier) resulting in a total well volume of 100 μl/treated well/replicate treatment. Assay plates are incu¬ bated for 48 hours and the results are determined by reading optical density (OD) with a BioRad microtiter plate reader model 3550 at a single wavelength of 595 nm. An OD reading is made at time zero (to) which is made immediately after sample application, and an OD reading is made at 48 hours after sample application (t 4 β). Fungal growth estimate is deter¬ mined by the difference in OD readings between to anji t 8 multiplied by a calculation value for fungal biomass. (The calculation value for fungal biomass is the relationship between fungal growth and optical density and was determined in separate experiments. The relationship between fungal growth and optical density was determined by growing fungi in 96 well microtiter plates, and harvesting the mycelium over time, at absorbance intervals of approximately 0.1 OD. The calculation value comes from the linear relationship between fungal biomass and OD for the specific fungus. It is the slope value obtained from the linear relationship. The calculation value for Ph is 4.91) Then % inhibition is determined from the difference between the biomass of the treatments and the biomass of the controls. AGO exhibited 60% inhibition of Ph at 1.7x10-4 IU/μl. Tests against Sn were conducted essentially like those for Ph except for the spore suspension preparation. A seven day old sporulating culture of Septoria nodorum on YMA agar is used to make the spore sus¬ pension. A small amount (<1 ml) of CDAA media is dropped onto an area of the culture with pink spore masses oozing from the pycnidia. The spores are mixed with the CDAA media by repeatedly drawing up and expelling them from the pipetter. The concentrated suspension is added to the total volume of CDAA required for the test, adjusting spore concentration to 50,000 spores/ml. The calculation value for Sn is 0.508. AGO exhibited 60% inhibition of Sn at 1.7x10-4 RJ/μl. Bacterial Assay Cultures of the bacteria Erwinia carotovora are maintained by streaking onto PDA plates and incubating at 24 °C in the dark. To prepare inoculum broth, a loop of actively growing bacteria (5-9 days old) is added to 50 ml of 1/4 strength PD broth in a 125 ml Erlenmeyer flask. The flask is placed on a shaker incubator (130 rpm) at 24 °C in the dark. After 24 hr, the bacteria are pelleted, resuspended in sterile deionized water, and three or four 100 μl aliquots are each placed in wells of a 96-well microtiter plate for readings. The microplate reader is set at 595 nm, and the average optical density of the wells is determined. This absorbance (ABS = optical density) number is used in the following formula to calculate colony forming units (CFUs) contained in the broth. CFU = (3 x 106) + [(3 x 108) x ABS] + [(5 x 108) ABS2] The broth is adjusted for use to 105 CFU. AGO completely controlled growth of E. carotovora at concentrations as low as 3x10-5 IU/μl. ENZYME IDENTIFICATION A number of methods may be devised to detect the production of a protein in a heterologous system such as plant cells. Western blot tech¬ niques may be used to detect a protein immunologically, or enzymatic or biological assays may be used to detect activity of the protein. Glucose Oxidase Enzymatic Assay A modification of a continuous spectrophotometric assay (Frederick et al., 1990) was utilized to establish GO activity. Aspergillus niger GO (Sigma) was used as a positive control. The reaction mixture con¬ sisted of 20 μg/ml horseradish peroxidase (Sigma), 0.32 mM Triton X-100- stabilized o-dianisidine solution (Sigma), and 0.1 M glucose in 75 mM sodium phosphate buffer (pH 5.0). To this was added 100 μl of various con¬ centrations of A. niger GO for the control reactions or 100 μl of sample derived from a heterologous source. The assay was performed at room temperature and the increase in absorbance was monitored at 460 nm. An alternate assay for glucose oxidase utilizing the reagent 4-amino-antipyrine (4-AAP) was optimized for use based on Gallo, 1981. The 5X 4-AAP reagent is prepared at 10 ml total volume with 0.68 g KH 2 P0 4 , 8.3 mg 4-AAP (0.82 mM), 25 μl Triton X-100, 0.0658 g crys¬ talline phenol, and 1000 U Horseradish peroxidase, with the pH adjusted to 5.0 with KOH. The assay is conducted by mixing 200μl of this 4-AAP reagent, 5 μl 1 mM FAD, 50 μl 1 M glucose; and the test sample (up to 750 μl). The result is read at OD508. Glucose Oxidase Biological Activity Assay A plug of 4-6 day old Ggt fungus was transferred onto fresh one- quarter-strength potato dextrose agar (Difco) plates. The fungus was grown at 22 °C for four days or until the circle of growth was about 2.5 cm. Using a sterile cork borer, wells were made in agar at 1 cm outside the circle of growth and 100 μl of buffer or sample derived from a heterologous source was placed in the wells. The fungus was grown for 24 hr at room temperature and examined for inhibition of growth. Immunological Detection of Glucose Oxidase Polyclonal antibodies to glucose oxidase produced by Aspergillus niger are available commercially from many sources, for example, Rockland, Inc., Gilbertsville, Pennsylvania. GENETIC TRANSFORMATION Cloning of the AGO Gene Total DNA was isolated from Aspergillus niger (ATCC 9029) and used as a template for PCR isolation of a glucose oxidase gene. PCR primers were based on the published sequence of the gene (Frederick et al; Kriechbaum et al.) and were designed to isolate the entire sequence of the gene including the signal sequence. In addition, in order to facilitate the incorporation of this gene into vectors appropriate for expression in heter- ologous bacterial, baculovirus or plant systems, the 5' PCR primer (SEQ ID NO:3) introduced Xbal and Bglll restriction endonuclease sites up¬ stream of the ATG start of translation of the gene. The 3' PCR primer (SEQ ID NO:4) introduced the BamHI and Kpnl restriction endonuclease sites immediately after the stop codon. The PCR fragment produced was cloned into pUCllδ as a Xbal/Kpnl fragment to create pMON22514 and was completely sequenced. The sequence (SEQ ID NO:l) exactly matched that of the published sequence. SEQ ID NO:2 is the corresponding amino acid sequence. Plant Gene Construction The expression of a plant gene which exists in double-stranded DNA form involves transcription of messenger RNA (mRNA) from one strand of the DNA by RNA polymerase enzyme, and the subsequent processing of the mRNA primary transcript inside the nucleus. This processing involves a 3' non-translated region which adds polyadenylate nucleotides to the 3' end of the RNA. Transcription of DNA into mRNA is regulated by a region of DNA usually referred to as the "promoter." The promoter region con¬ tains a sequence of bases that signals RNA polymerase to associate with the DNA and to initiate the transcription of mRNA using one of the DNA strands as a template to make a corresponding strand of RNA. A number of promoters which are active in plant cells have been described in the literature. These include the nopaline synthase (NOS) and octopine synthase (OCS) promoters (which are carried on tumor-inducing plasmids oi Agrobacterium tumefaciens), the cauliflower mosaic virus (CaMV) 19S and 35S promoters, the Figwort Mosaic Virus (FMV) 35S promoter, and the light-inducible promoter from the small subunit of ribulose 1,5-bis-phosphate carboxylase (ssRUBISCO, a very abundant plant polypeptide). All of these promoters have been used to create various types of DNA constructs which have been expressed in plants. U.S. Patent Number 5,034,322 (Fraley et al., 1991), herein incorporated by reference, discloses such uses. There are promoters known which will limit expression to particular plant parts or in response to particular stimuli. For example, potato tuber specific promoters, such as the patatin promoters or the promoters for the large or small subunits of ADPglucose pyrophosphorylase, could be used to obtain expression primarily in the tuber and thus, in combination with AGO, provide resistance to attacks on the tuber, such as by Erwinia. A fruit specific promoter would be desirable to impart resistance to Botrytis in strawberries or grapes. A root specific promoter would be desirable to obtain expression of AGO in wheat or barley to provide resistance to Ggt. One skilled in the art will know of many such plant part-specific promoters which would be useful in the present invention. Alternatively, the promoters utilized in the double-stranded DNA molecules may be selected to confer specific expression of AGO in response to fungal infection. The infection of plants by fungal pathogens triggers the induction of a wide array of proteins, termed defense-related or pathogenesis- related (PR) proteins [Bowles; Bol et al.; Linthorst]. Such defense-related or PR genes may encode phenylpropanoid metabolism enzymes (such as phenylalanine ammonia lyase, chalcone synthase, 4-coumarate coA ligase, coumaric acid 4-hydroxylase), proteins that modify plant cell walls (such as hydroxyproline-rich glycoproteins, glycine-rich proteins, peroxidases), enzymes (such as chitinases and glucanases) that degrade the fungal cell wall, thaumatin-like proteins, or proteins of as yet unknown function. The defense-related or PR genes have been isolated and characterized from a number of plant species. The promoters of these genes may be used to attain expression of AGO in transgenic plants when challenged with a pathogen, particularly a fungal pathogen such as Pi. Such promoters may derive from defense-related or PR genes isolated from potato itself [Fritzemeier et al.; Cuypers et al.; Logemann et al.; Matton and Brisson; Taylor et al.; Matton et al.; Schroder et al.]. In order to place the AGO gene under the control of a promoter induced by infection with P. infestans the promoter reported by Taylor et al. (1990) may be preferred. The particular promoter selected should be capable of causing suffi¬ cient expression of the enzyme coding sequence to result in the production of an effective amount of AGO. The promoters used in the DNA constructs (i.e. chimeric plant genes) of the present invention may be modified, if desired, to affect their control characteristics. For example, the CaMV 35S promoter may be ligated to the portion of the ssRUBISCO gene that represses the expres- sion of ssRUBISCO in the absence of light, to create a promoter which is active in leaves but not in roots. The resulting chimeric promoter may be used as described herein. For purposes of this description, the phrase "CaMV 35S" promoter thus includes variations of CaMV 35S promoter, e.g., promoters derived by means of ligation with operator regions, random or controlled mutagenesis, etc. Furthermore, the promoters may be altered to contain multiple "enhancer sequences" to assist in elevating gene expression. Examples of such enhancer sequences have been reported by Kay et al. An enhanced CaMV 35S promoter has been constructed as follows. A fragment of the CaMV 35S promoter extending between position -343 and +9 was previously constructed in pUC13. [Odell et al.] This segment contains a region identified as being necessary for maximal expression of the CaMV 35S promoter. It was excised as a Clal-Hindlll fragment, made blunt ended with DNA polymerase I (Clal fragment) and inserted into the Hindi site of pUC18. This upstream region of the 35S promoter was excised from this plasmid as a HindlH-EcoRV fragment (extending from -343 to -90) and inserted into the same plasmid between the Hindlll ι. Δ PstI sites. The enhanced CaMV 35S promoter (hereafter "CaMV E35S") thus contains a duplication of sequences between -343 and -90. [Kay et al.] The RNA produced by a DNA construct of the present invention also contains a 5' non-translated leader sequence. This sequence can be derived from the promoter selected to express the gene, and can be specif¬ ically modified so as to increase translation of the mRNA. The 5' non- translated regions can also be obtained from viral RNA's, from suitable eukaryotic genes, or from a synthetic gene sequence. The present inven¬ tion is not limited to constructs wherein the non-translated region is derived from the 5' non-translated sequence that accompanies the pro¬ moter sequence. Rather, the non-translated leader sequence can be derived from an unrelated promoter or coding sequence. For example, the petunia heat shock protein 70 (Hsp70) contains such a leader. [Winter] As noted above, the 3' non-translated region of the chimeric plant genes of the present invention contains a polyadenylation signal which functions in plants to cause the addition of adenylate nucleotides to the 3' end of the RNA. Examples of preferred 3' regions are (1) the 3' transcribed, non-translated regions containing the polyadenylate signal of Agrobac- terium tumor-inducing (Ti) plasmid genes, such as the nopaline synthase (NOS) gene and (2) plant genes like the soybean 7s storage protein genes and the pea ssRUBISCO E9 gene. [Fischhoff, et al.] Plant Transformation and Expression A chimeric plant gene containing a structural coding sequence of the present invention can be inserted into the genome of a plant by any suitable method. Suitable plant transformation vectors include those derived from a Ti plasmid of Agrobacterium tumefaciens, as well as those disclosed, e.g., by Herrera-Estrella (1983), Bevan (1983), Klee (1985) and EPO publication 0 120 516 (Schilperoort et al.). In addition to plant trans¬ formation vectors derived from the Ti or root-inducing (Ri) plasmids of Agrobacterium, alternative methods can be used to insert the DNA con¬ structs of this invention into plant cells. Such methods may involve, for example, the use of liposomes, electroporation, chemicals that increase free DNA uptake, free DNA delivery via microprojectile bombardment, and transformation using viruses or pollen. Plants which may be protected by the present invention include, but are not limited to, potatoes, tomatoes, wheat, corn, strawberries, grapes, as well as various ornamentals. Methods of tissue culture and plant regeneration are available for all of these types of plants. Transient Expression of Glucose Oxidase in Tobacco Plants A particularly useful plasmid cassette vector for transformation of dicotyledonous plants is pMON999. The expression cassette pMON999 consists of the CaMV E35S promoter, and the 3' end including polyadenyla¬ tion signals from the NOS gene. pMON999 includes Bglll, Kpnl and EcoRI sites for insertion of coding sequences and Notl-NotI sites flanking the plant gene expression cassette. The BglH/Kpnl fragment of pMON22514 containing the AGO coding region was inserted into pMON999 to create pMON22515. pMON22515 was electroporated into tobacco protoplasts. Expression of glucose oxidase by the transformed tobacco cells was confirmed by Western blot analysis as well as enzymatic assays. Stable Transformation of Dicots The shuttle vector for AGO was created by excising the AGO coding region as a BamHI/Bglll fragment from pMON22515. It was then placed in a pUC-based vector, and the resulting plasmid, pMON22579, contains the FMV promoter, the AGO coding region, and the 3' end including poly- adenylation signals from the NOS gene. The Notl/NotI fragment from this vector containing the FMV promoter, the AGO coding region, and the NOS gene 3' end including the polyadenylation signal was moved into the NotI restriction site of pMON17227 (WO 92/0449, Barry et al.) to generate the final Ti vector, pMON22587. As discussed above, an AGO gene can also be expressed in specific parts of a plant by using tissue-specific promoters. The patatin promoter expresses primarily in the tuber of the potato. A KpnI/Xbal fragment con¬ taining the AGO coding region was excised from pMON22514 and inserted into a pUC-based vector containing the patatin 1.0 promoter (Bevan et al., 1986) and the 3' end including polyadenylation signals from the NOS gene to create pMON22516. The NotI fragment of pMON22516 containing the patatin promoter, the AGO coding region and the NOS gene 3' end including the polyadenylation signal was then moved into the NotI restriction site of pMON17227, which was described above, to create the Ti plasmid vector, pMON22517. These vectors may be introduced into disarmed igrobacterium ABI and used to transform potato, tomato, or other explants in tissue culture. After selection for kanamycin or glyphosate resistance and plant regenera- tion, whole plants containing an AGO gene may be recovered. Expression of the glucose oxidase gene may be confirmed by Western blot analysis, enzyme assay, or bioassay. Expression of AGO by Transformed Potato Plants Protein was extracted from the tubers of potato plants which had been transformed with the Ti plasmid vector pMON22517 and were examined for the presence of glucose oxidase by Western blot analysis. High levels of glucose oxidase expression were detected in some of the plants. These levels of expression were confirmed by enzymatic assay using the 4-amino antipyrine system. Total protein was extracted from several of these tubers by grinding in 25mM Phosphate buffer pH7.0 + 5mM EDTA + lOOmM KC1. Protein was concentrated and washed with 12.5 mM Phosphate Buffer pH7.0. The protein extracted from tubers expressing AGO was tested against P. infestans in the 96-well plate assay in 12.5 mM Phosphate Buffer pH7.0. The results are shown in Table 1. At the highest level of protein tested, 21.2 μg/μl, Pi spores either remained ungerminated or growth from the spores was severely stunted when compared to the Hollow Vector (pMON17227) or Buffer control plant extracts. Table 1 Treatment Fungal Inhibition* Buffer control 0 Hollow vector control 2 pMON22517, line 9 3 pMON22517, line 30 3 *Scale: 0=no inhibition, l=slight inhibition, 2=moderate inhibition, 3=severe inhibition. Leaves of potato plants transformed with the Ti plasmid vector pMON22587 were tested for the presence of AGO by means of an enzymatic assay. The results are given in Table 2. As above, pMON17227- transformed potato plants were used as hollow vector control plants. Table 2 Expression Glucose oxidase Equivalent levels activityb toe Line # (%) fU/10 nεr X 10-4) (U/gFW) Rus. Bur. 0 0 0 22587-2 0.075 72.2 7.22 22587-3 0.150 126.4 12.64 22587-4 0.007 6.0 0.6 22587-12 0.125 88.2 8.82 22587-31 0.350 140.4 14.04 22587-32 0.350 121.0 12.10 22587-33 0.450 181.8 18.18 22587-34 0.003 1.2 0.12 a Expression level is indicated as the percentage of glucose oxidase in total extractable leaf protein, b Glucose oxidase activity in leaf extracts were determined by enzyme activity assay and calculated as units of the enzyme activity in total protein. c Units of glucose oxidase activity per gram fresh weight of leaf tissue (U/gFW) were calculated from the activity in total protein by the con¬ version factor of 10 μg total protein per gram fresh weight of leaf tissue. The leaves of potato plants transformed with the Ti plasmid vector pMON22587 were also tested for levels of H 2 0 by titanium chloride precipitation. In two fines the leaves were found to have levels of H 2 0 2 two- to four-fold higher than the leaves of nontransformed control plant. Disease-Resistant Potatoes Tubers expressing AGO were tested against Erwinia carotovora in a tuber disc assay. Tubers from 34 lines transformed with pMON22517 were tested for resistance to soft rot lesions. The lines were also tested for expression levels by Western blot analysis. The tubers were surface steri- lized according to the method of Yang et al. (1989). Two or three tubers per line were aseptically cut into discs 7-10mm thick, resulting in six to twelve discs per line. The discs were placed on moistened sterile Whatman #1 filter paper in petri dishes. The center of each disc was inoculated with 50,000 CFU of bacterial in 10 μl. The dishes were maintained in a high humidity environment for 3 days at 23 °C. Disease evaluations included measuring the length, radius, and depth of the resulting lesions. Dilutions of macerated tissue from within the lesion were used to determine the final number of bacteria per lesion. The results of this determination are presen¬ ted in Table 3. For the fines that appeared to be the most protected, all of the measured parameters were better than those of the Hollow Vector and Buffer control tubers. Tubers found to be expressing AGO at the highest level generally had the lowest level of bacteria in the lesions. Table 3 Expressionb LINE * Levels CFU X 109 Buffer Control null 16.76 Hollow vector null 14.32 22517-10 null 20.7 22517-24 null 20.09 22517-13 null 16.3 22517-12 null 19.26 22517-9 LOW 9.34 22517-28 LOW 13.56 22517-33 LOW 9.57 22517-14 LOW 8.22 22517-17 LOW 8.36 22517-19 LOW 9.37 22517-32 LOW 7.17 22517-20 LOW 7.4 22517-21 LOW 6.25 22517-34 LOW 4.44 22517-11 LOW 3.06 22517-8 LOW 1.5 22517-7 MEDIUM 12.88 22517-31 MEDIUM 12.06 22517-1 MEDIUM 7.54 22517-15 MEDIUM 6.7 22517-25 MEDIUM 12.25 22517-35 MEDIUM 6.81 22517-2 MEDIUM 3.52 22517-3 MEDIUM 1.26 22517-5 MEDIUM 1.4 22517-6 HIGH 15.74 22517-18 HIGH 2.675 22517-26 HIGH 4.55 22517-29 HIGH 4.35 22517'-4 HIGH 4.2 22517-30 HIGH 3.92 22517-16 HIGH 1.12 22517-23 HIGH 2.67 22517- 36 HIGH 0.855 a CFU = colony forming units b Expression levels determined by Western Blot Analysis Leaflets from plants transformed with pMON22587 and expressing AGO were tested for resistance to Pi. Fully expanded leaflets (~20 cm 2 ) were inoculated by adding droplets of 100 μl sporangium suspension of Phytophthora infestans to the center of the abaxial leaf surface. The inocula had a density of 105-106 sporangia per ml collected from 2-3 week old plates containing LB-V8 medium.. The inoculated leaflets were main¬ tained in Nunc Bio-Assay dishes (243 x 243 x 18 cm) with moisture pro¬ vided by wet filter paper at the bottom, and incubated in growth chambers at ~19oC with 16 h photoperiod. The development of symptoms was observed and infected areas on the leaflets were measured by overlaying each leaflet with a 5 mm x 5 mm transparent grid. For each line of leaflets, the mean of infected areas and the standard deviation were calculated. The transgenic lines expressing AGO showed significant control of the symptoms caused by Phytophthora infestans infection on the leaflets. The results of two lines are shown in Table 4. The symptom reduction was 47 and 57% as compared to controls (both nontransformed and hollow vector transformants). Table 4 Area of Infections (cm 2 ) Line No. 3 dpib 4 dpi 5 dpi 6 dpi Russet Burbank 1.2 2.1 4.2 7.1 17227-lc 1.6 2.7 4.7 8.7 22587-3d 0.4 0.8 1.1 3.0 22587-12d 0.5 1.3 2.3 3.7 a Area of infection is indicated as the mean of five leaflets. b Days post inoculation. c A control line transformed with vector only. d Transgenic lines expressing glucose oxidase. Stable Transformation of Monocots For transformation of monocots a vector was constructed with AGO and an intron particularly useful in increasing frequency of obtaining transformed plants which express a desired protein at high levels. The hsp70 intron disclosed in EP 602 193 (equivalent to U.S. Serial Number 08/181,364, Brown et al., incorporated herein by reference) was used. ρMON19477, disclosed therein, was cut, and the 800 bp Bglll-BamHI fragment containing the hsp70 intron was then cloned into the unique Bglll site in pMON22515, resulting in pMON22623. pMON22623 has been introduced into wheat cells by micropro- jectile bombardment using known methods (Vasil et al.) When transformed plants are recovered, their fungal resistance capacity, particularly to Ggt, will be assessed by known methods. All publications and patents mentioned in this specification are herein incorporated by reference as if each individual publication or patent was specifically and individually stated to be incorporated by reference. From the foregoing, it will be seen that this invention is one well adapted to attain all the ends and objects hereinabove set forth together with advantages which are obvious and which are inherent to the invention. It will be understood that certain features and subcombinations are of utility and may be employed without reference to other features and subcombinations. This is contemplated by and is within the scope of the claims. Since many possible embodiments may be made of the invention without departing from the scope thereof, it is to be understood that all matter herein set forth or shown in the accompanying drawings is to be interpreted as illustrative and not in a limiting sense. REFERENCES Barry, G.F., G. Kishore, and S.R. Padgette. "Glyphosate Tolerant 5-Enol- pyruvylshikimate-3-phosphate SynthasesJ PCT Appl. WO 92/04449, 1991. Bevan, M. et al. Nature. 304:184, 1983. Bevan, M. et al. Nucleic Acid Research. 14:4625, 1986. Bol, J. et al. Ann Rev of Phvtopathol.. 28:113-138, 1990. Bowles, D. Ann Rev of Biochem.. 59:873-907, 1990. Cuypers, B. et al. Mol Plant-Microbe Interactions. 1:157-160, 1988. Fischhoff, D.A. and Perlak, F.J. "Synthetic plant genes and method for preparation." European Patent Application, Publication Number 0 385 962, 1990. Frederick, K. et al. J. Biol. Chem.. 265:3793-3802. Fritzemeier, K. et al. Plant Phvsiol. 85:34-41, 1987. Gallo. Methods in Enzvmologv. 71:665-668, 1981. Herrera-Estrella, L. et al. Nature. 303:20-9, 1983. Kay, R. et al., Science. 236:1299-1302, 1987. Keil, M. et al. Nucleic Acids Res.. 14:5641 - 5650, 1986. Klee, H. J. et al. Bio/Technology. 3:637-642, 1985. Kim , K. et al. Phytopathology. 78:488-492, 1988. Kim, K. et al. Can. J. Microbiol.. 36:199-205, 1990. Kriechbaum M. et al. FEBS Lett, 255:63-66, 1989. Linthorst, H. J. M. Crit Rev Plant Sci. 10:123-150. Logemann, J. et al. Plant Cell. 1:151-158, 1989. Matton, D. and Brisson, N. Mol Plant-Microbe Interactions. 2:325-331, 1989. Matton, D. et al. Plant Mol Biol. 14:863-865, 1990. Nelson, C. et al. Proc. Natl. Acad. Sci. USA. 77:1975 - 1979, 1980. Odell, J. et al., Nature. 313:810, 1985. Schroder, M.et al. Plant J. 2:161-172, 1992. Taylor, J., et al. Molecular Plant-Microbe Interactions. 3:72-77, 1990. Vasil et al. Bio/Technologv 11: 1153-1158, 1993. Winter et al. Mol. Gen. Genet.. 221(2):315-19, 1988. SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: (A) NAME: Monsanto Company (B) STREET: 800 North Lindbergh Boulevard (C) CITY: St. Louis (D) STATE: Missouri (E) COUNTRY: United States of America (F) POSTAL CODE (ZIP): 63198 (G) TELEPHONE: (314)537-7286 (H) TELEFAX: (314)537-6047 (ii) TITLE OF INVENTION: Method of Controlling Plant Pathogens (iii) NUMBER OF SEQUENCES: 4 (iv) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patentln Release #1.0, Version #1.25 (EPO) (vi) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: US 08/161041 (B) FILING DATE: 24-NOV-1993 (2) INFORMATION FOR SEQ ID NO:l: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1848 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 16..1833 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:l: TCTAGAAGAT CTATC ATG CAG ACT CTC CTT GTG AGC TCG CTT GTG GTC TCC 51 Met Gin Thr Leu Leu Val Ser Ser Leu Val Val Ser 1 5 10 CTC GCT GCG GCC CTG CCA CAC TAC ATC AGG AGC AAT GGC ATT GAA GCC 99 Leu Ala Ala Ala Leu Pro His Tyr lie Arg Ser Asn Gly lie Glu Ala 15 20 25 AGC CTC CTG ACT GAT CCC AAG GAT GTC TCC GGC CGC ACG GTC GAC TAC 147 Ser Leu Leu Thr Asp Pro Lys Asp Val Ser Gly Arg Thr Val Asp Tyr 30 35 40 ATC ATC GCT GGT GGA GGT CTG ACT GGA CTC ACC ACC GCT GCT CGT CTG 195 lie lie Ala Gly Gly Gly Leu Thr Gly Leu Thr Thr Ala Ala Arg Leu 45 50 55 60 ACG GAG AAC CCC AAC ATC AGT GTG CTC GTC ATC GAA AGT GGC TCC TAC 243 Thr Glu Asn Pro Asn lie Ser Val Leu Val lie Glu Ser Gly Ser Tyr 65 70 75 GAG TCG GAC AGA GGT CCT ATC ATT GAG GAC CTG AAC GCC TAC GGC GAC 291 Glu Ser Asp Arg Gly Pro lie lie Glu Asp Leu Asn Ala Tyr Gly Asp 80 85 90 ATC TTT GGC AGC AGT GTA GAC CAC GCC TAC GAG ACC GTG GAG CTC GCT 339 lie Phe Gly Ser Ser Val Asp His Ala Tyr Glu Thr Val Glu Leu Ala 95 100 105 ACC AAC AAT CAA ACC GCG CTG ATC CGC TCC GGA AAT GGT CTC GGT GGC 387 Thr Asn Asn Gin Thr Ala Leu lie Arg Ser Gly Asn Gly Leu Gly Gly 110 115 120 TCT ACT CTA GTG AAT GGT GGC ACC TGG ACT CGC CCC CAC AAG GCA CAG 435 Ser Thr Leu Val Asn Gly Gly Thr Trp Thr Arg Pro His Lys Ala Gin 125 130 135 140 GTT GAC TCT TGG GAG ACT GTC TTT GGA AAT GAG GGC TGG AAC TGG GAC 483 Val Asp Ser Trp Glu Thr Val Phe Gly Asn Glu Gly Trp Asn Trp Asp 145 150 155 AAT GTG GCC GCC TAC TCC CTC CAG GCT GAG CGT GCT CGC GCA CCA AAT 531 Asn Val Ala Ala Tyr Ser Leu Gin Ala Glu Arg Ala Arg Ala Pro Asn 160 165 170 GCC AAA CAG ATC GCT GCT GGC CAC TAC TTC AAC GCA TCC TGC CAT GGT 579 Ala Lys Gin lie Ala Ala Gly His Tyr Phe Asn Ala Ser Cys His Gly 175 180 185 GTT AAT GGT ACT GTC CAT GCC GGA CCC CGC GAC ACC GGC GAT GAC TAT 627 Val Asn Gly Thr Val His Ala Gly Pro Arg Asp Thr Gly Asp Asp Tyr 190 195 200 TCT CCC ATC GTC AAG GCT CTC ATG AGC GCT GTC GAA GAC CGG GGC GTT 675 Ser Pro lie Val Lys Ala Leu Met Ser Ala Val Glu Asp Arg Gly Val 205 210 215 220 CCC ACC AAG AAA GAC TTC GGA TGC GGT GAC CCC CAT GGT GTG TCC ATG 723 Pro Thr Lys Lys Asp Phe Gly Cys Gly Asp Pro His Gly Val Ser Met 225 230 235 TTC CCC AAC ACC TTG CAC GAA GAC CAA GTG CGC TCC GAT GCC GCT CGC 771 Phe Pro Asn Thr Leu His Glu Asp Gin Val Arg Ser Asp Ala Ala Arg 240 245 250 GAA TGG CTA CTT CCC AAC TAC CAA CGT CCC AAC CTG CAA GTC CTG ACC 819 Glu Trp Leu Leu Pro Asn Tyr Gin Arg Pro Asn Leu Gin Val Leu Thr 255 260 265 GGA CAG TAT GTT GGT AAG GTG CTC CTT AGC CAG AAC GGC ACC ACC CCT 867 Gly Gin Tyr Val Gly Lys Val Leu Leu Ser Gin Asn Gly Thr Thr Pro 270 275 280 CGT GCC GTT GGC GTG GAA TTC GGC ACC CAC AAG GGC AAC ACC CAC AAC 915 Arg Ala Val Gly Val Glu Phe Gly Thr His Lys Gly Asn Thr His Asn 285 290 295 300 GTT TAC GCT AAG CAC GAG GTC CTC CTG GCC GCG GGC TCC GCT GTC TCT 963 Val Tyr Ala Lys His Glu Val Leu Leu Ala Ala Gly Ser Ala Val Ser 305 310 315 CCC ACA ATC CTC GAA TAT TCC GGT ATC GGA ATG AAG TCC ATC CTG GAG 1011 Pro Thr lie Leu Glu Tyr Ser Gly lie Gly Met Lys Ser lie Leu Glu 320 325 330 CCC CTT GGT ATC GAC ACC GTC GTT GAC CTG CCC GTC GGC TTG AAC CTG 1059 Pro Leu Gly lie Asp Thr Val Val Asp Leu Pro Val Gly Leu Asn Leu 335 340 345 CAG GAC CAG ACC ACC GCT ACC GTC CGC TCC CGC ATC ACC TCT GCT GGT 1107 Gin Asp Gin Thr Thr Ala Thr Val Arg Ser Arg lie Thr Ser Ala Gly 350 355 360 GCA GGA CAG GGA CAG GCC GCT TGG TTC GCC ACC TTC AAC GAG ACC TTT 1155 Ala Gly Gin Gly Gin Ala Ala Trp Phe Ala Thr Phe Asn Glu Thr Phe 365 370 375 380 GGT GAC TAT TCC GAA AAG GCA CAC GAG CTG CTC AAC ACC AAG CTG GAG 1203 Gly Asp Tyr Ser Glu Lys Ala His Glu Leu Leu Asn Thr Lys Leu Glu 385 390 395 CAG TGG GCC GAA GAG GCC GTC GCC CGT GGC GGA TTC CAC AAC ACC ACC 1251 Gin Trp Ala Glu Glu Ala Val Ala Arg Gly Gly Phe His Asn Thr Thr 400 405 410 GCC TTG CTC ATC CAG TAC GAG AAC TAC CGC GAC TGG ATT GTC AAC CAC 1299 Ala Leu Leu lie Gin Tyr Glu Asn Tyr Arg Asp Trp lie Val Asn His 415 420 425 AAC GTC GCG TAC TCG GAA CTC TTC CTC GAC ACT GCC GGA GTA GCC AGC 1347 Asn Val Ala Tyr Ser Glu Leu Phe Leu Asp Thr Ala Gly Val Ala Ser 430 435 440 TTC GAT GTG TGG GAC CTT CTG CCC TTC ACC CGA GGA TAC GTT CAC ATC 1395 Phe Asp Val Trp Asp Leu Leu Pro Phe Thr Arg Gly Tyr Val His lie 445 450 455 460 CTC GAC AAG GAC CCC TAC CTT CAC CAC TTC GCC TAC GAC CCT CAG TAC 1443 Leu Asp Lys Asp Pro Tyr Leu His His Phe Ala Tyr Asp Pro Gin Tyr 465 470 475 TTC CTC AAC GAG CTG GAC CTG CTC GGT CAG GCT GCC GCT ACT CAA CTG 1491 Phe Leu Asn Glu Leu Asp Leu Leu Gly Gin Ala Ala Ala Thr Gin Leu 480 485 490 GCC CGC AAC ATC TCC AAC TCC GGT GCC ATG CAG ACC TAC TTC GCT GGG 1539 Ala Arg Asn lie Ser Asn Ser Gly Ala Met Gin Thr Tyr Phe Ala Gly 495 500 505 GAG ACT ATC CCC GGT GAT AAC CTC GCG TAT GAT GCC GAT TTG AGC GCC 1587 Glu Thr lie Pro Gly Asp Asn Leu Ala Tyr Asp Ala Asp Leu Ser Ala 510 515 520 TGG ACT GAG TAC ATC CCG TAC CAC TTC CGT CCT AAC TAC CAT GGC GTG 1635 Trp Thr Glu Tyr lie Pro Tyr His Phe Arg Pro Asn Tyr His Gly Val 525 530 535 540 GGT ACT TGC TCC ATG ATG CCG AAG GAG ATG GGC GGT GTT GTT GAT AAT 1683 Gly Thr Cys Ser Met Met Pro Lys Glu Met Gly Gly Val Val Asp Asn 545 550 555 GCT GCC CGT GTG TAT GGT GTG CAG GGA CTG CGT GTC ATT GAT GGT TCT 1731 Ala Ala Arg Val Tyr Gly Val Gin Gly Leu Arg Val lie Asp Gly Ser 560 565 570 ATT CCT CCT ACG CAA ATG TCG TCC CAT GTC ATG ACG GTG TTC TAT GCC 1779 lie Pro Pro Thr Gin Met Ser Ser His Val Met Thr Val Phe Tyr Ala 575 580 585 ATG GCG CTA AAA ATT TCG GAT GCT ATC TTG GAA GAT TAT GCT TCC ATG 1827 Met Ala Leu Lys lie Ser Asp Ala lie Leu Glu Asp Tyr Ala Ser Met 590 595 600 CAG TGATAAGGAT CCGGTACC 1848 Gin 605 (2) INFORMATION FOR SEQ ID NO:2: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 605 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2: Met Gin Thr Leu Leu Val Ser Ser Leu Val Val Ser Leu Ala Ala Ala 1 5 10 15 Leu Pro His Tyr lie Arg Ser Asn Gly lie Glu Ala Ser Leu Leu Thr 20 25 30 Asp Pro Lys Asp Val Ser Gly Arg Thr Val Asp Tyr lie lie Ala Gly 35 40 45 Gly Gly Leu Thr Gly Leu Thr Thr Ala Ala Arg Leu Thr Glu Asn Pro 50 55 60 Asn lie Ser Val Leu Val lie Glu Ser Gly Ser Tyr Glu Ser Asp Arg 65 70 75 80 Gly Pro lie lie Glu Asp Leu Asn Ala Tyr Gly Asp lie Phe Gly Ser 85 90 95 Ser Val Asp His Ala Tyr Glu Thr Val Glu Leu Ala Thr Asn Asn Gin 100 105 110 Thr Ala Leu lie Arg Ser Gly Asn Gly Leu Gly Gly Ser Thr Leu Val 115 120 125 Asn Gly Gly Thr Trp Thr Arg Pro His Lys Ala Gin Val Asp Ser Trp 130 135 140 Glu Thr Val Phe Gly Asn Glu Gly Trp Asn Trp Asp Asn Val Ala Ala 145 150 155 160 Tyr Ser Leu Gin Ala Glu Arg Ala Arg Ala Pro Asn Ala Lys Gin lie 165 170 175 Ala Ala Gly His Tyr Phe Asn Ala Ser Cys His Gly Val Asn Gly Thr 180 185 190 Val His Ala Gly Pro Arg Asp Thr Gly Asp Asp Tyr Ser Pro lie Val 195 200 205 Lys Ala Leu Met Ser Ala Val Glu Asp Arg Gly Val Pro Thr Lys Lys 210 215 220 Asp Phe Gly Cys Gly Asp Pro His Gly Val Ser Met Phe Pro Asn Thr 225 230 235 240 Leu His Glu Asp Gin Val Arg Ser Asp Ala Ala Arg Glu Trp Leu Leu 245 250 255 Pro Asn Tyr Gin Arg Pro Asn Leu Gin Val Leu Thr Gly Gin Tyr Val 260 265 270 Gly Lys Val Leu Leu Ser Gin Asn Gly Thr Thr Pro Arg Ala Val Gly 275 280 285 Val Glu Phe Gly Thr His Lys Gly Asn Thr His Asn Val Tyr Ala Lys 290 295 300 His Glu Val Leu Leu Ala Ala Gly Ser Ala Val Ser Pro Thr lie Leu 305 310 315 320 Glu Tyr Ser Gly lie Gly Met Lys Ser lie Leu Glu Pro Leu Gly lie 325 330 335 Asp Thr Val Val Asp Leu Pro Val Gly Leu Asn Leu Gin Asp Gin Thr 340 345 350 Thr Ala Thr Val Arg Ser Arg lie Thr Ser Ala Gly Ala Gly Gin Gly 355 360 365 Gin Ala Ala Trp Phe Ala Thr Phe Asn Glu Thr Phe Gly Asp Tyr Ser 370 375 380 Glu Lys Ala His Glu Leu Leu Asn Thr Lys Leu Glu Gin Trp Ala Glu 385 390 395 400 Glu Ala Val Ala Arg Gly Gly Phe His Asn Thr Thr Ala Leu Leu lie 405 410 415 Gin Tyr Glu Asn Tyr Arg Asp Trp lie Val Asn His Asn Val Ala Tyr 420 425 430 Ser Glu Leu Phe Leu Asp Thr Ala Gly Val Ala Ser Phe Asp Val Trp 435 440 445 Asp Leu Leu Pro Phe Thr Arg Gly Tyr Val His lie Leu Asp Lys Asp 450 455 460 Pro Tyr Leu His His Phe Ala Tyr Asp Pro Gin Tyr Phe Leu Asn Glu 465 470 475 480 Leu Asp Leu Leu Gly Gin Ala Ala Ala Thr Gin Leu Ala Arg Asn lie 485 490 495 Ser Asn Ser Gly Ala Met Gin Thr Tyr Phe Ala Gly Glu Thr lie Pro 500 505 510 Gly Asp Asn Leu Ala Tyr Asp Ala Asp Leu Ser Ala Trp Thr Glu Tyr 515 520 525 lie Pro Tyr His Phe Arg Pro Asn Tyr His Gly Val Gly Thr Cys Ser 530 535 540 Met Met Pro Lys Glu Met Gly Gly Val Val Asp Asn Ala Ala Arg Val 545 550 555 560 Tyr Gly Val Gin Gly Leu Arg Val lie Asp Gly Ser lie Pro Pro Thr 565 570 575 Gin Met Ser Ser His Val Met Thr Val Phe Tyr Ala Met Ala Leu Lys 580 585 590 lie Ser Asp Ala lie Leu Glu Asp Tyr Ala Ser Met Gin 595 600 605 (2) INFORMATION FOR SEQ ID NO:3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 33 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3: CCATCTAGAA GATCTATCAT GCAGACTCTC CTT 33 (2) INFORMATION FOR SEQ ID NO:4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 36 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4: TGGGGTACCG GATCCTTATC ACTGCATGGA AGCATA 36

Claims: WHAT IS CLAIMED IS: 1. A recombinant, double-stranded DNA molecule comprising in operative sequence: a) a promoter which functions in plant cells to cause the production of an RNA sequence; b) a structural coding sequence that encodes for production of AGO; and c) a 3' non-translated region which functions in plant cells to cause the addition of polyadenylate nucleotides to the 3' end of the RNA sequence. 2. The DNA molecule of Claim 1 wherein said structural DNA sequence is SEQ ID NO:l. 3. The DNA molecule of Claim 1 wherein said promoter is selected from FMV35S and CaMV35S promoters. 4. The DNA molecule of Claim 1 wherein said promoter is induced by a pathogenic infection. 5. A method of producing genetically transformed, disease resistant plants, comprising the steps of: a) inserting into the genome of a plant cell a recombinant, double-stranded DNA molecule comprising (i) a promoter which functions in plant cells to cause the production of an RNA sequence; (ii) a structural coding sequence that causes the production of AGO; (iii) a 3' non-translated region which functions in said plant cells to cause the addition of polyadenylate nucleotides to the 3' end of the RNA sequence; b) obtaining transformed plant cells; and c) regenerating from the transformed plant cells genetically transformed plants which express AGO in an amount effective to reduce damage due to infection by a bacterial or fungal pathogen.. 6. The method of Claim 5 wherein said structural coding sequence is SEQ ID NO:l. 7. The method of Claim 5 wherein said promoter is selected from FMN35S and CaMV35S promoters. 8. The method of Claim 5 wherein said promoter is induced by pathogen infection. 9. The method of Claim 5 wherein said plants are potato or wheat plants. 10. A genetically transformed, disease resistant plant comprising a recombinant, double-stranded DΝA molecule comprising in operative sequence: a) a promoter which functions in plant cells to cause the production of an RΝA sequence; b) a structural coding sequence that encodes for production of AGO; and c) a 3' non-translated region which functions in plant cells to cause the addition of polyadenylate nucleotides to the 3' end of the RΝA sequence. 11. The plant of Claim 10 wherein said promoter is selected from FMV35S and CaMV35S promoters. 12. The plant of Claim 10 wherein said promoter is induced by pathogen infection. 13. The plant of Claim 10 wherein said structural coding sequence is SEQ ID NO: 1. 14. The plant of Claim 10 which is a potato or wheat plant.

Inventors: LAWRENCE ELLEN BRISKIN, LEVINE ELAINE BEATRICE, SHAH DILIPKUMAR MAGANLAL, LAWRENCE, ELLEN, BRISKIN, LEVINE, ELAINE, BEATRICE, SHAH, DILIPKUMAR, MAGANLAL
Applicants: MONSANTO CO, MONSANTO COMPANY
Application year: 1994
Main classification: C12N15
IPC codes: A01H5, A01N63, C12N5, C12N9, C12N15, C12R1